Philippou, A., Sehgal, P., Ungaro, R. C., Wang, K., Bagiella, E., Dubinsky, M. C., & Keefer, L. (2021). High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 28(6), 888–894. https://doi.org/10.1093/ibd/izab200

Abraham, B., Eksteen, B., Nedd, K., Kale, H., Patel, D., Stephens, J., Shelbaya, A., Chambers, R., & Soonasra, A. (2022). Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study). Advances in Therapy, 39(5), 2109–2127. https://doi.org/10.1007/s12325-022-02104-6

LaBere, B., Gutierrez, M. J., Wright, H., Garabedian, E., Ochs, H. D., Fuleihan, R. L., Secord, E., Marsh, R., Sullivan, K. E., Cunningham-Rundles, C., Notarangelo, L. D., & Chen, K. (2022). Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry. The Journal of Allergy and Clinical Immunology: In Practice, 10(5), 1325-1333.e5. https://doi.org/10.1016/j.jaip.2021.12.035

Forss, A., Clements, M., Bergman, D., Roelstraete, B., Kaplan, G. G., Myrelid, P., Halfvarson, J., Olén, O., & Ludvigsson, J. F. (2021). A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014. Alimentary Pharmacology & Therapeutics, 55(6), 691–699. Portico. https://doi.org/10.1111/apt.16735

Varma, S., Green, P. H., & Krishnareddy, S. (2022). Clinical Factors Associated With Positive Stool PCR for Gastrointestinal Pathogens in Celiac and Inflammatory Bowel Disease. Journal of Clinical Gastroenterology, 56(3), e196–e202. https://doi.org/10.1097/mcg.0000000000001657

Shi, C., Dawulieti, J., Shi, F., Yang, C., Qin, Q., Shi, T., Wang, L., Hu, H., Sun, M., Ren, L., Chen, F., Zhao, Y., Liu, F., Li, M., Mu, L., Liu, D., Shao, D., Leong, K. W., & She, J. (2022). A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease. Science Advances, 8(4). https://doi.org/10.1126/sciadv.abj2372

Rabinowitz, L. G., Zylberberg, H. M., Yang, J., Gold, S. L., Chesner, J., Ji, J., Hu, L., & Dubinsky, M. (2021). De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences, 67(8), 4033–4042. https://doi.org/10.1007/s10620-021-07257-y

Ludvigsson, J. F., Holmgren, J., Grip, O., Halfvarson, J., Askling, J., Sachs, M. C., & Olén, O. (2021). Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002–2017. Scandinavian Journal of Gastroenterology, 56(10), 1152–1162. https://doi.org/10.1080/00365521.2021.1924259